G. Steven Burrill

An introduction to Burrill Venture Capital

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

News

Biotech takes a beating in market meltdown October 01, 2008 | Press Release

Biotech outperforms market in May June 02, 2008 | Press Release

Biotech Treads Water in April May 01, 2008 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.


Submit a Business Plan

Do great things with us.Click here 
Venture Capital

 


Catalyst Biosciences is developing the next generation of biopharmaceuticals by harnessing the catalytic power of proteases. Proteases are naturally occurring protein-degrading enzymes that regulate a wide variety of biological processes. Catalyst is harnessing the power of these enzymes as bio-pharmaceuticals by redirecting them to degrade specific proteins that promote disease.

Website: http://www.catbio.com